PuSH - Publication Server of Helmholtz Zentrum München: The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Ackermann, M.* ; Kamp, J.C.* ; Werlein, C.* ; Walsh, C.L.* ; Stark, H.* ; Prade, V.M. ; Surabattula, R.* ; Wagner, W.L.* ; Disney, C.* ; Bodey, A.J.* ; Illig, T.* ; Leeming, D.J.* ; Karsdal, M.A.* ; Tzankov, A.* ; Boor, P.* ; Kühnel, M.P.* ; Länger, F.P.* ; Verleden, S.E.* ; Kvasnicka, H.M.* ; Kreipe, H.H.* ; Haverich, A.* ; Black, S.M.* ; Walch, A.* ; Tafforeau, P.* ; Lee, P.D.* ; Hoeper, M.M.* ; Welte, T.* ; Seeliger, B.* ; David, S.P.* ; Schuppan, D.* ; Mentzer, S.J.* ; Jonigk, D.D.*

The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling.

EBioMedicine 85:104296 (2022)

Publ. Version/Full Text

Research data

DOI

PMC

	Open Access Gold

Abstract
Metrics
Extra information

BACKGROUND: COVID-19 is characterized by a heterogeneous clinical presentation, ranging from mild symptoms to severe courses of disease. 9-20% of hospitalized patients with severe lung disease die from COVID-19 and a substantial number of survivors develop long-COVID. Our objective was to provide comprehensive insights into the pathophysiology of severe COVID-19 and to identify liquid biomarkers for disease severity and therapy response. METHODS: We studied a total of 85 lungs (n = 31 COVID autopsy samples; n = 7 influenza A autopsy samples; n = 18 interstitial lung disease explants; n = 24 healthy controls) using the highest resolution Synchrotron radiation-based hierarchical phase-contrast tomography, scanning electron microscopy of microvascular corrosion casts, immunohistochemistry, matrix-assisted laser desorption ionization mass spectrometry imaging, and analysis of mRNA expression and biological pathways. Plasma samples from all disease groups were used for liquid biomarker determination using ELISA. The anatomic/molecular data were analyzed as a function of patients' hospitalization time. FINDINGS: The observed patchy/mosaic appearance of COVID-19 in conventional lung imaging resulted from microvascular occlusion and secondary lobular ischemia. The length of hospitalization was associated with increased intussusceptive angiogenesis. This was associated with enhanced angiogenic, and fibrotic gene expression demonstrated by molecular profiling and metabolomic analysis. Increased plasma fibrosis markers correlated with their pulmonary tissue transcript levels and predicted disease severity. Plasma analysis confirmed distinct fibrosis biomarkers (TSP2, GDF15, IGFBP7, Pro-C3) that predicted the fatal trajectory in COVID-19. INTERPRETATION: Pulmonary severe COVID-19 is a consequence of secondary lobular microischemia and fibrotic remodelling, resulting in a distinctive form of fibrotic interstitial lung disease that contributes to long-COVID. FUNDING: This project was made possible by a number of funders. The full list can be found within the Declaration of interests / Acknowledgements section at the end of the manuscript.

Impact Factor

Scopus SNIP

Altmetric

11.205

0.000